Clarkston Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $501K | Hold |
2,700
| – | – | 0.01% | 126 |
|
|
2025
Q1 | $566K | Sell |
2,700
-400
| -13% | -$83.8K | 0.01% | 114 |
|
|
2024
Q4 | $551K | Sell |
3,100
-250
| -7% | -$44.4K | 0.01% | 117 |
|
|
2024
Q3 | $662K | Hold |
3,350
| – | – | 0.01% | 112 |
|
|
2024
Q2 | $575K | Hold |
3,350
| – | – | 0.01% | 116 |
|
|
2024
Q1 | $610K | Hold |
3,350
| – | – | 0.01% | 113 |
|
|
2023
Q4 | $519K | Hold |
3,350
| – | – | 0.01% | 111 |
|
|
2023
Q3 | $499K | Hold |
3,350
| – | – | 0.01% | 116 |
|
|
2023
Q2 | $451K | Hold |
3,350
| – | – | 0.01% | 118 |
|
|
2023
Q1 | $534K | Sell |
3,350
-300
| -8% | -$47.8K | 0.01% | 111 |
|
|
2022
Q4 | $590K | Hold |
3,650
| – | – | 0.01% | 110 |
|
|
2022
Q3 | $490K | Buy |
3,650
+50
| +1% | +$6.71K | 0.01% | 120 |
|
|
2022
Q2 | $551K | Hold |
3,600
| – | – | 0.01% | 120 |
|
|
2022
Q1 | $584K | Hold |
3,600
| – | – | 0.01% | 125 |
|
|
2021
Q4 | $487K | Hold |
3,600
| – | – | 0.01% | 121 |
|
|
2021
Q3 | $388K | Hold |
3,600
| – | – | 0.01% | 113 |
|
|
2021
Q2 | $406K | Hold |
3,600
| – | – | 0.01% | 114 |
|
|
2021
Q1 | $390K | Buy |
+3,600
| New | +$390K | 0.01% | 114 |
|